Manual de Hipertensión Arterial en la Práctica Clínica de ... - SAMFyC

Manual de Hipertensión Arterial en la Práctica Clínica de Atención Primaria
Hipertensión en situaciones especiales
47. Padwal R, Laupacis A. Antihypertensive Therapy and Incidence of Type 2 Diabetes: A systematic
review Diabetes Care 2004;27:247-55.
48. Padwal R, Mamdani M, Alter DA, Hux JE, Rothwell DM, Tu K. Laupacis A. Antihypertensive therapy
and incidence of type 2 diabetes in an elderly cohort.. Diabetes Care 2004; 27:2458-63.
49. Gress T. W., Nieto F. J., Shahar E., Wofford M. R., Brancati F. L. Hypertension and Antihypertensive
Therapy as Risk Factors for Type 2 Diabetes Mellitus The Atherosclerosis Risk in Communities
Study. N Eng J Med 2000; 342:905-12.
50. Kostis JB, Wilson AC, Freudenberger RS, Cosgrove NM, Pressel SL, Davis BR; SHEP Collaborative
Research Group. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with
isolated systolic hypertension with and without diabetes Am J Cardiol 2005; 95:29-35.
51. Davis BR, Furberg CD, Wright JT Jr, Cutler JA, Whelton P; ALLHAT Collaborative Research Group.
ALLHAT: setting the record straight. Ann Intern Med 2004;141(1):39-46.
52. The Heart Outomes Prevention Evaluation Study Investigators. Effects of an angiotensinconverting-enzyme
inhibitor, ramipril, on cardiovascular events in high-risk patientes. N Eng J Med
2000;342:145-153.
53. Casas JP, Chua W, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani AD, MacAllister RJ. Effect of
inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes:
systematic review and meta-analysis. Lancet. 2005;366(9502):2026-33.
54. Verdecchia P, Reboldi G, Angeli F, Borgioni C, Gattobigio R, Filippucci L, et al.. Adverse prognostic
significance of new diabetes in treated hypertensive subjects. Hypertension 2004;43:963-9.
55. Am J Cardiol 2005; 95:29-35
56. Strippoli G, Craig M, Deeks J, Schena FP, Craig JC. Effects of angiotensin converting enzyme
inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic
nephropathy: systematic review. BMJ 2004 Oct 9;329(7470):828.
57. Barnett AH, Bain SC, Bouter P, Karlberg B, Madsbad S, Jervell J et al. Angiotensin-receptor
blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med
2004; 351: 1952-61.
58. National Institute for Clinical Excellence (NICE). Management of hypertension in adults in primary
care. Clinical Guideline 18. Agosto, 2004. Disponible en: www.nice.org.uk
Grupo de Hipertensión Arterial
Sociedad Andaluza de Medicina de Familia
106